<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01188083</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00007471</org_study_id>
    <secondary_id>Emory-Vos-SweetBev</secondary_id>
    <nct_id>NCT01188083</nct_id>
  </id_info>
  <brief_title>Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis</brief_title>
  <acronym>Sweet Bev</acronym>
  <official_title>Effects of Dietary Fructose Reduction in Children With Hepatic Steatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary Objectives:

        1. To determine whether a 4 week reduction in dietary fructose intake improves hepatic
           steatosis in overweight children who have a baseline high fructose consumption and
           hepatic steatosis.

        2. To determine if a 4 week reduction of dietary fructose improves fasting plasma
           triglycerides, free fatty acids, very low-density lipoprotein, insulin and glucose as
           well as post-prandial levels in response to a high fructose meal.

        3. To determine if a 4 week reduction of dietary fructose improves markers of oxidative
           stress.

      Study Design: A blinded randomized study comparing glucose beverages to isocaloric fructose
      beverages administered over 4 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Planned Sample Size: Phase 1) 96 subjects Phase 2) 40 subjects

      Patient Population: Overweight Hispanic children with non-alcoholic fatty-liver disease age
      11 to 18 years who are stable and not taking any chronic medication with no recent acute
      illnesses.

      Definitions:

        -  BMI &gt;95th %tile for age and gender

        -  Self-identified as Hispanic/Latino

        -  Baseline hepatic fat fraction &gt; 10% (Have nonalcoholic fatty liver disease)

        -  Sweetened beverage intake of at least 24 ounces/day
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hepatic Fat</measure>
    <time_frame>2 &amp; 4 Weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma Triglycerides</measure>
    <time_frame>2 &amp; 4 Weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Non-alcoholic Fatty-liver Disease</condition>
  <arm_group>
    <arm_group_label>Fructose Drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will drink 3-8oz drinks per day for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose Drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will drink 3-8oz drinks per day for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fructose Drink</intervention_name>
    <description>Fructose Based beverage 8 oz</description>
    <arm_group_label>Fructose Drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Glucose Drink</intervention_name>
    <description>Glucose Based beverage 8 oz per drink x 3 per day x 4 weeks</description>
    <arm_group_label>Glucose Drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 85th %tile

          -  Self identified as Hispanic

          -  Age 11-18 years

          -  Baseline hepatic fat fraction &gt;8%

          -  Self reported sugar beverage intake of at least 24 oz (equivalent to 3 sugar sweetened
             drinks per day).

        Exclusion Criteria:

          -  Currently attempting weight gain or weight loss

          -  Cirrhosis visible on baseline MRI

          -  Renal insufficiency found on screening labs (creatinine &gt; 2)

          -  Recent acute illness within past 4 weeks (defined by fever &gt; 100.4ÂºF)

          -  Pregnancy

          -  Chronic illness requiring medication including diabetes

          -  Fasting glucose &gt;120 on screening labs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Vos, Md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory Children's Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2010</study_first_submitted>
  <study_first_submitted_qc>August 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2010</study_first_posted>
  <last_update_submitted>November 20, 2013</last_update_submitted>
  <last_update_submitted_qc>November 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Miriam Vos, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>NASH</keyword>
  <keyword>non-alcoholic fatty-liver disease</keyword>
  <keyword>Hispanic</keyword>
  <keyword>overweight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

